JAMA Psychiatry

Article	Citations
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	853
Error in Results	642
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	471
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	400
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	366
Assumptions and Limitations of the Synthetic Control Method	335
Diagnosing and Treating ADHD in Adults	320
An Opportunity to Advance Cannabis Science—DEA Rescheduling	266
Managerial and Organizational Challenges in the Age of AI	229
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	221
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	215
The Reliability of Traumatic and Adverse Experiences	187
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	179
Potential Lessons for DSM From Contemporary Philosophy of Science	177
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	172
Healing Ethno-Racial Trauma in Black Communities	168
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	167
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA	165
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	164
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	149
Moving Beyond Medications That Act at the μ Receptor in the Treatment of Opioid Use Disorder	148
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	143
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	141
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	135
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	128

Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings	122
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	120
Race and Ethnicity of Editorial Board Members and Editors as an Indicator of Structural Racism in Psychiatry and Neuroscience Journals	117
Error in Byline	116
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness	114
JAMA Psychiatry	114
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	112
JAMA Network Call for Papers on Health and the 2024 US Election	110
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	110
Hyperalgesia in Patients With a History of Opioid Use Disorder	108
Errors in Figures 1 and 2	108
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	108
Living Alone and Drug Overdose Deaths in the US	108
JAMA Psychiatry	103
Addiction Medicine Physicians and Medicinal Cannabinoids	101
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	101
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	96
Searching the Brain for the Cause of Psychosis	96
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction	95
Perinatal Mental Health Outcomes Following Natural Disasters	93
Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic	92
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	92
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	91
Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis	89
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	87
JAMA Psychiatry	85
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?	84
JAMA Psychiatry—The Year in Review, 2021	84
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity	82
Associating Violence With Schizophrenia—Risks and Biases—Reply	82
JAMA Psychiatry	81
Errors in Figures 3, 4, and 5	79
Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression	78
Trends in Outpatient Psychotherapy Among Adults in the US	77
Expanding Current Approaches to Solve the Opioid Crisis	77
Evaluation of a Model to Target High-risk Psychiatric Inpatients for an Intensive Postdischarge Suicide Prevention Intervention	76
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study	76
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	76
Limitations for Assessing Optimism and Physical Functioning in Women—Reply	74
Implementation Strategies Used and Reported in Brief Suicide Prevention Intervention Studies	73
JAMA Psychiatry	72
New Directions in Research on Heterogeneity of Treatment Effects for Major Depression	70
Psychosis Spectrum Symptoms Before and After Adolescent Cannabis Use Initiation	69
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply	69
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder	69
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	68
Neurobiological, Psychosocial, and Behavioral Mechanisms Mediating Associations Between Physical Activity and Psychiatric Symptoms in Youth in the Netherlands	68
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents	68
Stratified Care vs Stepped Care for Depression	67
Association of Antihypertensive Drug Target Genes With Psychiatric Disorders	67

Social Determinants of Health and Suicide-Related Outcomes	65
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder	65
Error in Figure 2	64
Errors in Text, Tables, and Figure	64
Errors in Author Affiliations, Table, and Figure 3	64
Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy	63
Treating Bipolar Depression Using Psilocybin—Validity Threats Regarding Efficacy and Safety	63
Reducing the Risks of Nuclear War	63
A Case for Permanent Adoption of Expanded Telehealth Services and Prescribing Flexibilities for Opioid Use Disorder	63
Suicide Risk—A Specific Intervention Target	63
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity—Reply	62
Do Not Rule Out Double-blind Placebo Run-in Periods for Randomized Clinical Trials	62
Written Exposure Therapy Finds Solid Footing Alongside First-Line Psychotherapies for Posttraumatic Stress Disorder	61
Bright Light Therapy as Add-On to Inpatient Treatment in Youth With Moderate to Severe Depression	60
All-Cause and Cause-Specific Mortality Among Individuals With Hypochondriasis	60
Right-Based Mental Health Care—Advantages of Tax-Financed Universal Mental Health Care	59
Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk	59
Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder	59
The Need for Functional Assessments in School-Based Mental Health Intervention Research	59
Family Genetic Risk Scores and the Genetic Architecture of Major Affective and Psychotic Disorders in a Swedish National Sample	58
Association Between Failures in Perceptual Updating and the Severity of Psychosis in Schizophrenia	58
Cognitive Behavior Therapy for Mental Disorders in Adults	58
Ultrarare Coding Variants and Cognitive Function in Schizophrenia	57
Association of Receipt of Opioid Use Disorder–Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19	57
Assessment of Disruptive Life Events for Individuals Diagnosed With Schizophrenia or Bipolar I Disorder Using Data From a Consumer Credit Reporting Agency	57
Association of Ambient Temperature With the Prevalence of Intimate Partner Violence Among Partnered Women in Low- and Middle-Income South Asian Countries	55
Lifetime Suicide Attempts in Otherwise Psychiatrically Healthy Individuals	55
Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021	54
Psychomotor Slowing in Psychosis and Inhibitory Repetitive Transcranial Magnetic Stimulation	54
Emotional Experience of People With Schizophrenia and People at Risk for Psychosis	53
Adverse Childhood Experiences and Mental Distress Among US Adults by Sexual Orientation	53
Association of Racial Discrimination With Neural Response to Threat in Black Women in the US Exposed to Trauma	53
Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US	52
Brief Cognitive Behavioral Therapy for Suicidal Inpatients	52
Genetic and Phenotypic Features of Schizophrenia in the UK Biobank	52
Rural and Urban Trends in Mental Health Readmissions	52
Prospective and Retrospective Measures of Child Maltreatment and Their Association With Psychopathology	52
Suicide Risk in Medicare Patients With Schizophrenia Across the Life Span	52
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses	52
The Rapid Rise in Investment in Psychedelics—Cart Before the Horse	50
JAMA Psychiatry	50
Errors in Byline and Abstract	49
Transdisciplinary Science and Research Training in Psychiatry	49
Sex Differences in Autism Heritability and Likelihood	49
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	49
Effect of General Practitioner Training in a Collaborative Child Mental Health Care Program on Children’s Mental Health Outcomes in a Low-Resource Setting	48
Errors in Results and Tables	48
Toward 90-90-90 Goals for Global Mental Health	48
Error in Title of Figure 1	48
Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections	47
Genetic Liability to Posttraumatic Stress Disorder Symptoms and Its Association With Cardiometabolic and Respiratory Outcomes	47
JAMA Psychiatry—The Year in Review 2024	47
Striatal Activity to Reward Anticipation as a Moderator of the Association Between Early Behavioral Inhibition and Changes in Anxiety and Depressive Symptoms From Adolescence to Adulthood	47
Integrated Nicotine Replacement and Behavioral Support to Reduce Smoking in Opioid Agonist Therapy	46
Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder	46
Suicidal Ideation and Suicide Attempts After Direct or Indirect Psychotherapy	45
Acupuncture for Combat-Related Posttraumatic Stress Disorder	45
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression	45
The Course of General Cognitive Ability in Individuals With Psychotic Disorders	45
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape	44
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis	44
Implementation and Effectiveness of Nonspecialist-Delivered Interventions for Perinatal Mental Health in High-Income Countries	43
Challenges to Behavioral Health and Injury Surveillance During the COVID-19 Pandemic	43
VA/Department of Defense Clinical Practice Guideline for PTSD and ASD	43
Considerations Regarding Antipsychotic Drug Prescriptions Among People With Dementia During the COVID-19 Pandemic	43
Combination Antidepressant Therapy vs Monotherapy—Further Considerations—Reply	42
Female Physician Suicide Compared to the General Population	42
JAMA Psychiatry	41
Complex Interaction of Lithium With Kidney and Bone Health	41
Error in Figure 1	41
Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk—Reply	41
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety	41
Potential of Control Conditions for Nonspecific Treatment-Effects in Noninferiority Trials—Reply	41
JAMA Psychiatry	40
Prescription Stimulant Prescribing, Nonmedical Use, and Shortages	40
Why Hippocampal Glutamate Levels Are Elevated in Schizophrenia	39
Differences in Insurance Coverage for Individuals With Schizophrenia After Implementation of the Patient Protection and Affordable Care Act	39
Error in Figure	39
Informant Effect on Placebo Response in Mental Disorders—Reply	38
Understanding Placebo Mechanisms to Reduce Attrition in Psychiatric Trials	38

COVID-19 and Risk for Mental Disorders Among Adults in Denmark	38
Neuromelanin-Sensitive Magnetic Resonance Imaging as a Proxy Marker for Catecholamine Function in Psychiatry	38
Mental Health Care Support in Rural India	38
Effects of a Smartphone-Based Self-management Intervention for Individuals With Bipolar Disorder on Relapse, Symptom Burden, and Quality of Life	38
The Hidden Epidemic of Opioid Overdoses During the Coronavirus Disease 2019 Pandemic	37
Brain Morphometry Normative Modeling—Omit Global Thickness—Reply	37
Mental Health Treatment Gap—The Implementation Problem as a Research Problem	37
Associations Between Early Life Adversity, Reproduction-Oriented Life Strategy, and Borderline Personality Disorder	36
Association of Cardiovascular Health With Risk of Clinically Relevant Depressive Symptoms	36
Investing in a Research Workforce With Personal Experience of Serious Mental Illness	36
Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain	35
RETRACTED: Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis	35
Written Exposure Therapy vs Prolonged Exposure Therapy in the Treatment of Posttraumatic Stress Disorder	34
Effect of Technology-Enhanced Screening in Addition to Standard Targeted Clinician Education on the Duration of Untreated Psychosis	34
Data Errors in Table	34
Functional Connectivity of the Nucleus Accumbens and Changes in Appetite in Patients With Depression	34
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure	33
COP27 Climate Change Conference—Urgent Action Needed for Africa and the World	33
Patterns of Brain Maturation in Autism and Their Molecular Associations	33
Change to Open Access Status	33
Coding Error for the Sex Variable in a Meta-analysis	33
Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021	33
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure—Reply	33
Posttraumatic Stress Disorder, Obesity, and Accelerated Epigenetic Aging Among US Military Veterans	33
Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder	32
Distinct Convergent Brain Alterations in Sleep Disorders and Sleep Deprivation	32
Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing	32
International Variation in Clozapine Hematologic Monitoring—A Call for Action	32
Association of Multigenerational Family History of Depression With Lifetime Depressive and Other Psychiatric Disorders in Children	32
Lessons Learned From Drug Decriminalization Remedies in British Columbia	32
Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway	32
Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression	31
Association of Oxidative Stress–Induced Nucleic Acid Damage With Psychiatric Disorders in Adults	31
Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders	31
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	30
Preaddiction—A Missing Concept for Treating Substance Use Disorders	30
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	30
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	30
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	30
Association of 24-Hour Activity Pattern Phenotypes With Depression Symptoms and Cognitive Performance in Aging	30
Long-term Arrhythmia Detection Using an Implantable Loop Recorder in Patients Receiving Psychotropic Medication	29
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability—Reply	28
JAMA Psychiatry Editorial Fellow	28
Challenges to Behavioral Health and Injury Surveillance During the COVID-19 Pandemic—Reply	28
JAMA Psychiatry Peer Reviewers in 2021	27
Improving the Assessment of COVID-19–Associated Posttraumatic Stress Disorder	27
Mental Health Service Use Before First Diagnosis of a Psychotic Disorder	27
Error in Results and in the Figure 3B Label and Plotted Values	27
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation	27
Value-Based Payment and Behavioral Health	27
Considerations in Publishing a Psychiatric Randomized Clinical Trial With Kenyan Children	27
Evolutionary Inquiries Into the Origin and Nature of Mental Disorders	27
JAMA Psychiatry Editorial Fellow	27
Clinician Suicide Risk Assessment for Prediction of Suicide Attempt in a Large Health Care System	26
Suicidality Calls to a National Helpline After a Terror Attack and War	26
Cognitive Function in People With Familial Risk of Depression	26
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System	26
Psychopharmacologic Considerations for Transgender and Gender Diverse People	26
Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections	26
Notice of Retraction: Worthington MA et al. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach. JAMA Psychiatry. 2023;80(10):1017-1025.	26
The Healthy Brain and Child Development Study—Shedding Light on Opioid Exposure, COVID-19, and Health Disparities	25
Social Disconnection as a Global Behavioral Epidemic—A Call to Action About a Major Health Risk Factor	25
Antipsychotic Medications and Mortality in Children and Young Adults	25
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	25
Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	25
An Atlas of Genetic Correlations and Genetically Informed Associations Linking Psychiatric and Immune-Related Phenotypes	25
Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder	25
Error in Figure 2	24
Change to Open Access Status	24
Preliminary Research Priorities for Factors Influencing Individual Outcomes for Users of the US National Suicide Prevention Lifeline	24
Association Between Physical Activity and Risk of Depression	24
Errors in Response Rate, Effect Sizes, and Confidence Intervals	24
Climate Events, Displacement, and Mental Health—Uprooted	23
SSRIs in Pregnancy—What Offspring Brain Volumes Can and Cannot Tell Us—Reply	23
JAMA Psychiatry	23
Error in Display of Author Name	23
Errors in Network Meta-Analysis of Generalized Anxiety Disorder Psychotherapies	23
Ten Practical Recommendations for Improving Blinding Integrity and Reporting in Psychotherapy Trials	22
Antidepressant Use and Manic Episodes in Children and Adolescents With Unipolar Depression	22
Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression	22
Addressing the Escalating Problems That Patients Encounter When Filling Buprenorphine Prescriptions	22
Years of Life Lost to Drug Overdose Among Black Female Individuals in the US, 2015-2021	22
Error in Figure Caption	22
Promoting Social Prescribing in Psychiatry—Using Shared Decision-Making and Peer Support	22
Grief-Specific Cognitive Behavioral Therapy vs Present-Centered Therapy	22
National Data on Age Gradients in Well-being Among US Adults	21
Transmission of Mental Disorders in Adolescent Peer Networks	21
Sleep Abnormalities in Different Clinical Stages of Psychosis	21
Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder	21
Polygenic Risk Scores Derived From Varying Definitions of Depression and Risk of Depression	21
Gratitude and Mortality Among Older US Female Nurses	21
Potential of Control Conditions for Nonspecific Treatment Effects in Noninferiority Trials	21
Error in Results	20
Beyond Voluntariness—Ethics and Incentives for Contraception	20
Identifying and Preparing for the Mental Health Burden of Climate Change	20